Center Articles and Publications

Countering the Posteradication Threat of Smallpox and Polio  
D.A. Henderson

Clinical Infectious Diseases. 2002;34(1):79-83. © 2002 by the Infectious Diseases Society of America. All rights reserved.

Abstract: After eradication, there is a small but finite risk that smallpox and/or poliomyelitis viruses could accidentally escape from a laboratory or be released intentionally. The reintroduction of either virus into a highly susceptible population could develop into a serious catastrophe. To counter such an occurrence will require the use of vaccine, perhaps in substantial quantities. In the United States, new stocks of smallpox vaccine are being procured and arrangements are being made for a standby production facility. Similar provisions need to be considered for polio. To counter an epidemic of polio will require the use of the oral vaccine, which is presently theWorld Health Organization–recommended vaccine of choice for countries throughout the developing world. In these countries, its continued use is advised because of its ability to induce intestinal immunity, its ability to spread to other susceptible household members and to protect them, its ease of administration, and its low cost.
   

Note: Full article available on the publisher's website.

Links will open in a new browser window. To return to the Center for Biosecurity of UPMC close the window in which the publication appears.